首页> 美国政府科技报告 >Antibodies Specific for Toxic Amyloid Beta Protein Oligomers.
【24h】

Antibodies Specific for Toxic Amyloid Beta Protein Oligomers.

机译:特异于有毒的淀粉样蛋白β蛋白低聚物的抗体。

获取原文

摘要

The present invention provides compositions and methods for diagnosing Alzheimer's disease (AD). In particular, the present invention provides monoclonal antibodies that specifically bind to soluble, non-fibrillar oligomeric amyloid .beta. protein assemblies proteolytically derived from the transmembrane amyloid precursor protein (APP) while not reacting with fibrillar amyloid .beta. protein assemblies, monoclonal antibodies that specifically bind to fibrillar amyloid .beta. protein assemblies that do not react with soluble, non-fibrillar oligomeric amyloid .beta. protein assemblies, and methods of use of these compositions in the diagnosis of Alzheimer's disease, as well as methods to monitor treatment and/or disease progression of AD in patients.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号